ProcDNA is a global consulting firm. We fuse design thinking with cutting-edge tech to create game-changing Commercial Analytics and Technology solutions for our clients. We're a passionate team of 200+ across 6 offices, all growing and learning together since our launch during the pandemic. Here, you won't be stuck in a cubicle -you'll be out in the open water, shaping the future with brilliant minds. At ProcDNA, innovation isn't just encouraged, it's ingrained in our DNA.
ProcDNA的外部链接
Today is Rare Disease Day - a reminder that while each rare disease may affect only a few, together they impact millions worldwide. Yet, awareness remains low, and many challenges persist. ? How much do you know about rare diseases? Take the poll and test your knowledge! ? #ProcDNA #RareDiseaseDay #KnowRare #ShineForRare #RareButNotAlone #HealthcareInnovation #PatientFirst #ClinicalTrials
此处无法显示此内容
在领英 APP 中访问此内容等
Smarter Insights, Stronger Market Success! Want to outpace competitors, refine messaging, and maximize brand uptake? AI-powered analytics can help you: - Monitor competitor moves - Optimize commercial execution - Drive HCP adoption & patient access ? Discover how a top cardiology brand grew 25% with smart commercialization. Are you ready to lead the market? Contact Us: https://lnkd.in/ghpSGv8p ? #ProcDNA #PharmaMarketing #LifeSciences #DataDrivenDecisions #CommercialStrategy #HealthcareTrends #FutureOfPharma
As part of PROMISE by ProcDNA, we conducted a CUET 2025 guidance session at NeeV- A Learning Centre, helping students to navigate the application process, ensuring they had the necessary documents, and guiding them in filling the application forms.? ? Beyond academic support, we also distributed essential stationery items to Class 10th and 12th students, equipping them with the tools they needed for their upcoming board exams.? ? #ProcDNAPROMISE #CSR #CUET2025 #EducationForAll #ProcDNA
Meet us at Pharma USA 2025! Join Roshan Alvares, Partner at ProcDNA, at Pharma USA 2025—the premier event where industry leaders tackle the future of tech-driven innovation, patient-centric strategies, and market access in life sciences. ? ?? March 18-19, 2025 | Pennsylvania Convention Center ? Let’s connect and drive impactful change together! ? #PharmaUSA2025 #HealthcareInnovation #LifeSciences #PharmaTrends #MarketAccess #MedicalAffairs #DigitalHealth #ProcDNA #Networking #REpharmaUSA
Pioneering a Breakthrough in CTX Treatment!?The FDA has approved Ctexli (chenodiol)—the first-ever treatment for cerebrotendinous xanthomatosis (CTX), a rare lipid storage disorder. Ctexli helps restore chenodeoxycholic acid levels, reducing harmful cholesterol metabolite buildup. A game-changer for CTX patients! Backed by clinical trials showing significant reductions in plasma cholestanol and urine 23S-pentol levels, Ctexli? marks a new era in metabolic disorder treatments. Read more: https://lnkd.in/esUf7HMi #CTX #RareDisease #LipidDisorders #DrugLaunch #FDAApproval #InnovationInMedicine #Biotech #ProcDNA
We're thrilled to announce that ProcDNA ranked #15 in the Vault Top Consulting Asia-Pacific 2025 list! This recognition reflects the passion, innovation, and dedication of our entire community—team members, partners, and clients—who drive our success every day. As we continue to lead in AI, commercial analytics, and technology solutions, this milestone fuels our commitment to making an even greater impact in the industry. A big thank you to everyone who’s been part of this journey! See the full rankings here: https://lnkd.in/gg5tKmwC #ProcDNA #VaultRankings #TopConsulting #LifeSciences #AI #Analytics #Technology #Innovation
Stay Ahead with Data-Driven Insights! From boosting KOL engagement by 85% to uncovering competitor share-of-scientific voice, Auxo empowers smarter decisions for market success. Are you ready to optimize your strategy? #ProcDNA #SmartInsights #MaximumImpact #MarketIntelligence #DigitalStrategy #CompetitiveEdge #PharmaMarketing
A Breakthrough in Rare Disease Care!?The FDA has approved Gomekli (mirdametinib), offering new hope for patients with symptomatic, inoperable plexiform neurofibromas associated with NF1. This approval marks a monumental step forward in the treatment of genetic disorders, providing a life-changing alternative for those in need. Read more: https://lnkd.in/gYQp8iBd #NF1Awareness #MEKInhibitor #RareDiseaseTreatment #LifeSciences #HealthcareInnovation #Biotech #DrugDiscovery #PharmaceuticalIndustry #MedicalBreakthrough #ProcDNA
Struggling to turn insights into action? AUXO Medical Insights bridges the gap, ensuring every data point drives meaningful change.?Read the full article by Rupesh Tyagi (Ph.D). #MSLs #MedicalAffairs #PharmaStrategy #AUXO #ProcDNA #LifeSciencesStrategy #PharmaLeadership
Leadership, vision, and resilience—qualities that define great presidents and drive innovation in every field. On this Presidents' Day, we celebrate the power of bold decisions and transformative leadership that inspire progress. Happy Presidents' Day! #PresidentsDay #Leadership #Innovation #ProcDNA